ACT Brief: AI, Equity, and Innovation in Clinical Research
In the latest Applied Clinical Trials Brief, we discuss how AstraZeneca is redefining gastric cancer care through the MATTERHORN trial.
Gen Li from Phesi shares insights on how AI and patient data are advancing global trial equity.
The FDA has unveiled new draft guidance to streamline biosimilar development.
- AstraZeneca's advances in gastric cancer
- AI-powered patient data improving global trial diversity
- New FDA guidance for biosimilar development
Join us tomorrow for more insights shaping the future of clinical operations and drug development.
Author's summary: AI and innovation drive clinical research forward.
More News
- This Longevity Startup Is Bringing Anti-Aging Gene Therapy to Human Trials
- Can the United States Immediately Return to Nuclear Testing?
- Paint by Numbers Kit: What Is a DTF Printer and How It Enhances Your Designs | NorthPennNow
- Thursday: Invasions, Violations, and Abductions Across West Bank
- 2025 NBA Cup TRACKER: Scores, Schedule, Standings
- McKenna says he has had 'no conversations' about Celtic job and insists he is 'in the middle' of 'long-term project' with Ipswich
- Billie Eilish Calls on Billionaires to Do More for People in Need
- Stranger Things 5 trailer shows way more than we were ready for
- Kerala Blasters pip Rajasthan Utd 1-0The Shillong Times
- Dean Lewis Shares Statement Following Misconduct Allegations